We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




European Pathogenomics Network Adopts Common Research Agenda

By Biotechdaily staff writers
Posted on 04 Jun 2007
A European Union initiative has launched a research consortium that will concentrate on understanding the genome of pathogenic microorganisms (a new field called pathogenomics) and exploiting this knowledge to advance the cause of disease control.

The program to broaden the research effort on pathogenic microorganisms officially began in 2005 when the European Commission committed 6.7 millions euros (about US$9 million) over five years to form the European Network of Excellence EuroPathoGenomics (NoE EPG). More...
The network comprises 37 scientific laboratories from 13 different countries with headquarters at the University of Würzburg (Germany).

Since its establishment only two years ago, NoE EPG has completed a central virtual cell strain collection, which allows for the rapid searching of suitable data. Furthermore, the EuroPathoGenomics Graduate Academy (EGA) has been established, with more than 50 students participating in a number of training programs. The members of the network have now adopted a common research agenda, which lays out the core scientific challenges for the years to come and places emphasis on two aims in particular. In the future, researchers will focus more on the interaction between pathogens and hosts, rather than exclusively analyzing disease-causing microorganisms in isolation. In addition, microbiologists will call upon the expertise of bioinformatic experts to better manage the multitude of data that is produced in modern genomic research.

Another goal of the agenda is better cooperation between basic scientists and clinicians. "Our scientific language is not well understood by clinicians. We should learn more from each other,” said Dr. Werner Goebel, professor of molecular microbiology at the University of Würzburg (Germany).


Related Links:
European Network of Excellence EuroPathoGenomics
University of Würzburg

Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automated MALDI-TOF MS System
EXS 3000
Automatic Hematology Analyzer
DH-800 Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.